Curran Terrie Insider Trading Activity

Average Profitability
28.42%
Insider Buys Quantity
2
Insider Buys Sum
$252,860.59
Insider Sells Quantity
8
Insider Sells Sum
$1.34M

Insider Activity of Curran Terrie

According to the SEC Form 4 filings, Curran Terrie, being in a position of

  1. director at Arcutis Biotherapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 28124 shares for $705,008,
    over all time since 2024-11-11, has bought 0 shares, and sold 36811 share for $799,246.

Biography of Curran Terrie

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $705,0082100

Comparison of Insiders on Amount of Buys and Sells

2026-08-27SaleArcutis Biotherapeutics, Inc.
ARQT
director
27,052
0.0218%
$25.03$677,095+5.63%
2026-08-20SaleArcutis Biotherapeutics, Inc.
ARQT
director
1,072
0.0008%
$26.04$27,912+3.02%
2025-01-21SalePhathom Pharmaceuticals, Inc.
PHAT
President and Chief Executive
19,109
0.0281%
$6.59$125,884+41.09%
2024-11-11SaleArcutis Biotherapeutics, Inc.
ARQT
director
8,687
0.0074%
$10.85$94,238+33.9%
2024-07-15SalePhathom Pharmaceuticals, Inc.
PHAT
President and Chief Executive
33,848
0.0663%
$11.72$396,699-30.9%
2024-03-22SalePhathom Pharmaceuticals, Inc.
PHAT
President and Chief Executive
16,851
0.0238%
$9.11$153,513-6.26%
2023-04-06PurchasePhathom Pharmaceuticals, Inc.
PHAT
President and Chief Executive
12,919
0.0318%
$7.82$101,025+34.94%
2023-03-01SalePhathom Pharmaceuticals, Inc.
PHAT
President and Chief Executive
1,436
0.0033%
$8.54$12,265+13.21%
2023-01-20SalePhathom Pharmaceuticals, Inc.
PHAT
President and Chief Executive
5,821
0.0134%
$8.20$47,729+20.27%
2022-11-21SalePhathom Pharmaceuticals, Inc.
PHAT
President and Chief Executive
1,526
0.0038%
$9.60$14,650+9.65%
2022-05-13PurchasePhathom Pharmaceuticals, Inc.
PHAT
President and Chief Executive
20,500
0.0497%
$7.41$151,835+21.9%
2021-03-22SalePhathom Pharmaceuticals, Inc.
PHAT
President and Chief Executive
11,513
0.0316%
$43.32$498,751-26.14%
Total: 12
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.